Expression of the scaffold connector enhancer of kinase suppressor of Ras 1 (CNKSR1) is correlated with clinical outcome in pancreatic cancer

Table 2 Demographics, tumor characteristics, and treatment by CNKSR1 expression status

		CNKSR1 Low (N = 34)	%	CNKSR1 High (N = 83)	%	P
Age group						0.72
	<64	13	38	36	42
	65+	21	62	50	58
Race						0.22
	White	23	68	47	55
	Asian/PI	6	18	29	34
	Black or Hispanic	5	15	10	12
Gender						0.82
	Male	17	50	41	48
	Female	17	50	45	52
Grade						0.04
	Well Differentiated (1)	18	53	47	55
	Moderately Diff. (2).	14	41	20	23
	Poorly Diff. (3).	2	6	19	22
Stage						0.86
	Localized	4	12	8	9
	Regional	20	59	49	57
	Distant	10	29	29	34
TNM (N)						0.70
	Lymph Node Negative (N0)	10	29	20	23
	Regional Lymph Nodes (N1)	11	32	34	40
	Unknown (NX)	13	38	32	37
TNM (M)						0.11
	No Metastasis (M0)	21	62	56	65
	Distant Metastasis (M1)	10	29	29	34
Resection						0.87
	Yes	20	59	52	60
	No	14	41	34	40
Radiation						0.24
	Yes	6	18	24	28
	No	28	82	62	72
Location						0.11
	Head	15	44	52	60
	Body/Tail	5	15	15	17
	Unknown	14	41	19	22

CNKSR1 expression status (low = 0,1; high = 2,3 staining intensity) for pancreatic cancer subjects by demographic, tumor characteristic and treatment option variables

ISSN: 1471-2407